Transcript Slide 1

Spring 2008:
features & functionality overview
Julie Gordon, Product Director
Presented at SLA DPHT Spring Meeting, St Petersburg, Florida
What does Inteleos include?
Launched in May 2006
• 10,000+ brand drug records
– 16,400+ indications
– 70% in active development
• Previewing at SLA PHT
– 9000+ US generic drugs
– New design
– Improved search capabilities
– Expanded content
Brand drug coverage
• Preclinical > launch > post marketing, includes
associated licensing activity
• Comprehensive FDA submission & approval filings
• Competitor profile
• Tracking advancements in technological innovations:
– bio-specific antibodies
– modified release mechanisms
– gene therapy
• Detailed clinical trial coverage – summarized per drug
record including links to ClinicalTrials.gov
• Full-text archive of selected articles from The Pink
Sheet and links to related press releases
Straight to the information
• Search & filter features, including:
– Product type, method of delivery
– Discontinued by phase
– Development timelines
• Flexible reporting
–
–
–
–
Analysis of data in graphical or chart displays
Multi-format exporting
Save search results
Share content with colleagues online
• Update alert
– Keywords & search queries
Injection - intravenous, 10mg/ml
COMPARISON ANALYSIS
PIPELINE MATRIX
What’s new?
• New design
• Improved usability
– Full Boolean searching
– Drug name instead of brand/generic/code
– Better organization of search and analysis pages
• Searchable development timelines
• Pharmacokinetic data for FDA approved drugs
• LINKING TO GENERIC DRUGS
• Searchable EMEA submission and approval details
Generics coverage
• FDA tentative approvals and approved generics
• Links back to brand drugs
• Continuous updates of FDA Drug Master Files
• Full indication coverage
• Identification of generic equivalencies
• Orange Book approved dosage forms
• To Come:
– linked and searchable Paragraph IV data
– selected articles from The Pink Sheet
• SCREEN SHOTS
– DMF files
• filter option
• export option
Inteleos
• Seamless linking between brand and generic
drugs
• Comprehensive and searchable FDA and EMEA
submission/approval details
• Tracking drug and biologic development
• Flexible search and export options
• Dynamic analysis tools
Thank you
For more information please visit our
booth